What's in Shenyang Sunshine Pharmaceutical Co., LTD.'s pipeline?

Shenyang Sunshine Pharmaceutical Co., LTD. has 19 drugs in our index: 2 marketed, 0 filed, 1 in Phase 3, 4 in Phase 2, 12 in Phase 1.

Which companies overlap with Shenyang Sunshine Pharmaceutical Co., LTD.'s portfolio?

Top competitors by shared drug class: Amgen, Centro de Atencion e Investigacion Medica, Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd., Eisai Inc., First Affiliated Hospital Xi'an Jiaotong University.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/shenyang-sunshine-pharmaceutical-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Shenyang Sunshine Pharmaceutical Co., LTD. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Shenyang Sunshine Pharmaceutical Co., LTD. pipeline: 2 marketed, 0 filed, 1 Phase 3, 4 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 1 Phase 3 4 Phase 2 12 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
EPIAO®	EPIAO®	marketed			Other
TPO	TPO	marketed	Thrombopoietin receptor agonist	c-Mpl (thrombopoietin receptor)	Hematology
PD-1 Inhibitor + Chemotherapy	PD-1 Inhibitor + Chemotherapy	phase 3	PD-1 inhibitor + chemotherapy combination	PD-1	Oncology

Therapeutic area mix

Hematology · 1
Oncology · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Amgen · 1 shared drug class
Centro de Atencion e Investigacion Medica · 1 shared drug class
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · 1 shared drug class
Eisai Inc. · 1 shared drug class
First Affiliated Hospital Xi'an Jiaotong University · 1 shared drug class
GlaxoSmithKline · 1 shared drug class
Hvidovre University Hospital · 1 shared drug class
Institute of Hematology & Blood Diseases Hospital, China · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Shenyang Sunshine Pharmaceutical Co., LTD.:

Cite this brief

Drug Landscape (2026). Shenyang Sunshine Pharmaceutical Co., LTD. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/shenyang-sunshine-pharmaceutical-co-ltd. Accessed 2026-05-16.